Effect of Presbyopic Correction Lens on Humphrey Visual Field Testing in Patients With Multifocal Intraocular Lens
Glaucoma, Cataract Senile
About this trial
This is an interventional treatment trial for Glaucoma focused on measuring cataract, glaucoma, multifocal intraocular lens, presbyopia, cataract surgery
Eligibility Criteria
Inclusion Criteria:
- Glaucomatous and non-glaucomatous patients
- Age older than 18 years
- A history of uneventful phacoemulsification with MIOL implantation at least one month before participation
- Distant best-corrected visual acuity (BCVA) equal to or better than 20/30
- Near BCVA of at least Jaeger 2
Exclusion Criteria:
- The inability to perform reliable visual field testing (fixation loss, false positive or false negative more than 25%)
- A history of postoperative complications
- Moderate to advanced visual field defects (MD less than - 6 dB)
- Any other concurrent ocular diseases, except well-controlled glaucoma.
Sites / Locations
- Naris Kitnarong
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Glaucomatous arm
Non-glaucomatous arm
Mild stage glaucomatous patients age more than 18 years old, a history of uneventful phacoemulsification with MIOL implantation at least 1 month before participation, distant best-corrected visual acuity (BCVA) equal to or better than 20/30, near BCVA at least Jaeger 2.
Pseudophakic participants without glaucoma, age more than 18 years old, a history of uneventful phacoemulsification with MIOL implantation at least 1 month before participation, distant best-corrected visual acuity (BCVA) equal to or better than 20/30, near BCVA at least Jaeger 2.